HP
Henry E. Pelish
Chief Scientific Officer

Henry E. Pelish insider trades: Nuvalent (NUVL) stock sales

Chief Scientific Officer, Nuvalent Last trade Jul 9, 2026 20 Form 4 filings
$4.5M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Henry reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 9, 2026NUVL↓ Sell$261K
Apr 9, 2026NUVL↓ Sell$323K
Mar 13, 2026NUVL↓ Sell$3.4M
Jan 6, 2026NUVL↓ Sell$502K
Oct 15, 2025NUVL↓ Sell$1.3M
Oct 14, 2025NUVL↓ Sell$895K
Sep 10, 2025NUVL↓ Sell$294K
Aug 7, 2025NUVL↓ Sell$412K
Jul 10, 2025NUVL↓ Sell$614K
Jun 27, 2025NUVL↓ Sell$863K
Jun 6, 2025NUVL↓ Sell$16K
Jan 6, 2025NUVL↓ Sell$198K
Sep 16, 2024NUVL↓ Sell$3.2M
Aug 23, 2024NUVL↓ Sell$893K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NUVL insiders

Open-market trades in the last 12 months

About Henry E. Pelish's insider trades

Henry E. Pelish is Chief Scientific Officer at Nuvalent (NUVL). Since Aug 23, 2024, Henry has reported no open-market purchases and 14 sales worth $13.2M on SEC Form 4. In the last 12 months: 4 sales ($4.5M).

Their filings also include option exercises (13 filings), grants and awards (4 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.